Zivo Bioscience, Inc. (ZIVO) stock
ZIVOOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$6.80+0.30 (+4.62%)
Close on Oct 19, 2026Market cap $25.96MP/E –Yield –
Zivo Bioscience profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Zivo Bioscience's profit margin for the twelve months ending Sep 30, 2025 was -4059.7%. For fiscal 2024 it was -8513.4%, against -28127.2% the year before. The highest annual figure on record is -2629.3% in fiscal 2011.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -8513.4% | +19613.8 |
| FY2023 | Dec 31, 2023 | -28127.2% | +17401.4 |
| FY2020 | Dec 31, 2020 | -45528.6% | −42899.3 |
| FY2011 | Dec 31, 2011 | -2629.3% | +5980.5 |
| FY2010 | Dec 31, 2010 | -8609.8% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2025 | Sep 30, 2025 | -1574.2% | +2005.0 |
| Q2 FY2025 | Jun 30, 2025 | -3071.6% | +13102.5 |
| Q4 FY2024 | Dec 31, 2024 | -1779.3% | +13686.1 |
| Q3 FY2024 | Sep 30, 2024 | -7201.9% | +43923.3 |
| Q1 FY2024 | Mar 31, 2024 | -3579.2% | +9135.7 |
| Q4 FY2023 | Dec 31, 2023 | -16174.1% | – |
| Q3 FY2023 | Sep 30, 2023 | -15465.4% | – |
| Q2 FY2023 | Jun 30, 2023 | -51125.2% | – |
| Q1 FY2020 | Mar 31, 2020 | -12714.9% | – |
See a number that looks wrong?